Alessandra Romano
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Immune cells in cancer
Most-Cited Works
- → Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study(2020)551 cited
- → Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial(2011)320 cited
- → Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients(2011)267 cited
- → Impact of Oral Microbiome in Periodontal Health and Periodontitis: A Critical Review on Prevention and Treatment(2022)246 cited
- → Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial(2018)193 cited
- → Immunological Dysregulation in Multiple Myeloma Microenvironment(2014)123 cited
- → Immunotherapy in Acute Myeloid Leukemia: Where We Stand(2021)96 cited
- → Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)(2016)92 cited
- → Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy(2014)91 cited
- → Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients(2014)84 cited